News & Analysis on Clinical Trial Services & Contract Research And Development
The bulk of biotech companies are firmly rooted towards the foot of the ladder of corporate evolution. Precious few can realistically claim to be at the top end of the evolutionary scale with full R&D capabilities, global reach and a strong presence...
Sweden's Biacore International, a specialist in surface plasmon resonance technologies, has launched its Biacore 3000 GxP (Good Manufacturing Practice/Good Laboratory Practice) Package, which will strengthen the system's use in preclinical and...
Shareholders at Swiss pharmaceutical company Roche welcomed the start of a new era as the company summarised recent events, including the divestment of the vitamins business, at its annual general meeting yesterday.
Drug discovery company Genaissance Pharmaceuticals is to acquire bankrupt applied genetics company DNA Sciences for €1.2 million in cash.
As the lead story today on In-Pharmatechnologist.com highlights, the European brain-drain is far from slowing down with the US continuing to attract researchers and entrepreneurs. A fact that has had, and will continue to have, a serious impact on...